D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 130 Citations 76,210 680 World Ranking 997 National Ranking 32

Research.com Recognitions

Awards & Achievements

2020 - Fellow of the Royal Society of Canada Academy of Science

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

His main research concerns Lung cancer, Cancer research, Pathology, Internal medicine and Cancer. His Lung cancer study combines topics from a wide range of disciplines, such as Immunohistochemistry, Immunology, Carcinoma, Stage and Adenocarcinoma. Ming-Sound Tsao has researched Cancer research in several fields, including Cell, Protein kinase B, Pancreatic cancer, Carcinogenesis and Oncogene.

His work deals with themes such as Cell culture, Respiratory disease, Lung, Metastasis and Tumor progression, which intersect with Pathology. His Internal medicine research includes themes of Surgery and Oncology. His Cancer study is concerned with the field of Genetics as a whole.

His most cited work include:

  • Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network (2762 citations)
  • Comprehensive genomic characterization of squamous cell lung cancers (2590 citations)
  • The landscape of somatic copy-number alteration across human cancers (2544 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Lung cancer, Cancer research, Internal medicine, Oncology and Pathology. The study incorporates disciplines such as Cancer, Adenocarcinoma, Carcinoma and Lung in addition to Lung cancer. Particularly relevant to Metastasis is his body of work in Cancer.

His Cancer research study combines topics in areas such as Pancreatic cancer, Carcinogenesis, Oncogene, Immunology and KRAS. His Oncology study incorporates themes from Phases of clinical research, Bioinformatics, Stage, Proportional hazards model and Biomarker. Ming-Sound Tsao focuses mostly in the field of Pathology, narrowing it down to matters related to Cell and, in some cases, Molecular biology.

He most often published in these fields:

  • Lung cancer (52.63%)
  • Cancer research (49.16%)
  • Internal medicine (35.50%)

What were the highlights of his more recent work (between 2017-2021)?

  • Lung cancer (52.63%)
  • Cancer research (49.16%)
  • Internal medicine (35.50%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Lung cancer, Cancer research, Internal medicine, Oncology and Cancer. His study explores the link between Lung cancer and topics such as Adenocarcinoma that cross with problems in Lung. He has included themes like Mutant, Organoid, KRAS, Carcinoma and In vivo in his Cancer research study.

His KRAS course of study focuses on Proto-oncogene tyrosine-protein kinase Src and Guanine nucleotide exchange factor and Carcinogenesis. In his research on the topic of Oncology, Immune checkpoint inhibitors is strongly related with PD-L1. His studies deal with areas such as Cytotoxic T cell, Computational biology and Hazard ratio as well as Cancer.

Between 2017 and 2021, his most popular works were:

  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology (289 citations)
  • PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project. (276 citations)
  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology (227 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

Lung cancer, Internal medicine, Oncology, Cancer research and Cancer are his primary areas of study. His Lung cancer research is multidisciplinary, relying on both Clinical trial, Malignancy, Targeted therapy, Carcinoma and Biomarker. His study in the field of Poorly differentiated is also linked to topics like Best practice.

Ming-Sound Tsao has researched Oncology in several fields, including Immunohistochemistry, Guideline, Colorectal cancer and PD-L1. His study in Cancer research is interdisciplinary in nature, drawing from both Collagen receptor, Lysyl oxidase, Prostate cancer and Tumor progression. The study incorporates disciplines such as National Lung Screening Trial, Lung cancer screening, Concordance, Hazard ratio and Receiver operating characteristic in addition to Cancer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Nature (2014)

3773 Citations

The landscape of somatic copy-number alteration across human cancers

Rameen Beroukhim;Craig H. Mermel;Craig H. Mermel;Dale Porter;Guo Wei.
Nature (2010)

2993 Citations

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification

William D. Travis;Elisabeth Brambilla;Andrew G. Nicholson;Yasushi Yatabe.
Journal of Thoracic Oncology (2015)

2376 Citations

Comprehensive genomic characterization of squamous cell lung cancers

Peter S. Hammerman;Doug Voet;Michael S. Lawrence;Douglas Voet.
Nature (2012)

2278 Citations

Erlotinib in lung cancer - molecular and clinical predictors of outcome.

Ming Sound Tsao;Akira Sakurada;Jean Claude Cutz;Jean Claude Cutz;Chang Qi Zhu;Chang Qi Zhu.
The New England Journal of Medicine (2005)

2212 Citations

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

Timothy Winton;Robert Livingston;David H Johnson;James Rigas.
The New England Journal of Medicine (2005)

2092 Citations

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

Peter Goldstraw;Kari Chansky;John Crowley;Ramon Rami-Porta.
Journal of Thoracic Oncology (2016)

1784 Citations

Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation

Klaus P. Hoeflich;Juan Luo;Elizabeth A. Rubie;Ming-Sound Tsao.
Nature (2000)

1644 Citations

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Andrew V. Biankin;Andrew V. Biankin;Andrew V. Biankin;Nicola Waddell;Karin S. Kassahn;Marie Claude Gingras.
Nature (2012)

1519 Citations

International network of cancer genome projects

Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
Nature (2010)

1460 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ming-Sound Tsao

Matthew Meyerson

Matthew Meyerson

Harvard University

Publications: 207

Ignacio I. Wistuba

Ignacio I. Wistuba

The University of Texas MD Anderson Cancer Center

Publications: 185

Gad Getz

Gad Getz

Broad Institute

Publications: 136

John D. Minna

John D. Minna

The University of Texas Southwestern Medical Center

Publications: 122

Rameen Beroukhim

Rameen Beroukhim

Harvard University

Publications: 122

Rafael Rosell

Rafael Rosell

Autonomous University of Barcelona

Publications: 118

Christopher I. Amos

Christopher I. Amos

Baylor College of Medicine

Publications: 108

Frances A. Shepherd

Frances A. Shepherd

Princess Margaret Cancer Centre

Publications: 107

John V. Heymach

John V. Heymach

The University of Texas MD Anderson Cancer Center

Publications: 105

Yi-Long Wu

Yi-Long Wu

Guangdong Provincial People’s Hospital

Publications: 102

Paul C. Boutros

Paul C. Boutros

University of California, Los Angeles

Publications: 102

Andrew V. Biankin

Andrew V. Biankin

University of Glasgow

Publications: 99

Gordon B. Mills

Gordon B. Mills

Oregon Health & Science University

Publications: 99

David C. Christiani

David C. Christiani

Harvard University

Publications: 94

William C. Hahn

William C. Hahn

Harvard University

Publications: 92

William D. Travis

William D. Travis

Memorial Sloan Kettering Cancer Center

Publications: 92

Something went wrong. Please try again later.